PolyNovo Limited (CALZF)
OTCMKTS · Delayed Price · Currency is USD
0.8180
0.00 (0.00%)
Sep 3, 2025, 8:00 PM EDT
PolyNovo Employees
PolyNovo had 301 employees as of June 30, 2025. The number of employees increased by 47 or 18.50% compared to the previous year.
Employees
301
Change (1Y)
47
Growth (1Y)
18.50%
Revenue / Employee
$280,320
Profits / Employee
$28,781
Market Cap
691.34M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 301 | 47 | 18.50% |
Jun 30, 2024 | 254 | 36 | 16.51% |
Jun 30, 2023 | 218 | 66 | 43.42% |
Jun 30, 2022 | 152 | 46 | 43.40% |
Jun 30, 2021 | 106 | 28 | 35.90% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Elite Pharmaceuticals | 68 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
CytoDyn | 13 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
PolyNovo News
- 6 months ago - PolyNovo chief executive steps down after dispute with chairman - The Australian Financial Review
- 6 months ago - David Williams says he makes no apologies for ‘aggressive’ style - The Australian Financial Review
- 1 year ago - Polynovo Ltd (CALZF) (Q4 2024) Earnings Call Transcript Highlights: Record Revenue and ... - GuruFocus